Dr. Sven Kili, MD, PhD
Scientific Advisor
Dr. Kili has a strong track record of success in developing and commercialising innovative advanced therapies. Dr. Kili’s focus is utilising a commercially-minded and pragmatic approach to advanced therapy development, he has supported a number of programs through clinical development (phase II/ III/ IV), product registration and reimbursement activities.
Dr. Kili is also a pharmaceutical physician and clinician who has extensive surgical and medical clinical experience with a strong patient focus.
IAG, Image Analysis Group
Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.
Image Management Platform
Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.
Careers
In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.